Aengus Mac Sweeney

Aengus Mac Sweeney

Auto-generated profile, based on publicly available information

Aengus Mac Sweeney

Idorsia Pharmaceuticals Ltd. Translational Sciences Allschwil Switzerland

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2003 in Molecular Cell
Verified
Journal Article
Closed access
MDMrudula Donepudi
Mrudula Donepudi
ASAengus Mac Sweeney
Aengus Mac Sweeney
CBChristophe Briand
Christophe Briand
MGMarkus G Grütter
Markus G Grütter

29 March 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
ASAnna Schubart
Anna Schubart
KAKaren Anderson
Karen Anderson
NMNello Mainolfi
Nello Mainolfi
HSHolger Sellner
Holger Sellner
TETakeru Ehara
Takeru Ehara
JEJörg Eder
Jörg Eder
Dysregulation of the alternative complement pathway (AP) predisposes individuals to a number of diseases including paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and C3 glomerulopathy. Moreover, glomerular Ig deposits can lead to complement-driven nephropathies. Here we describe the discovery of a highly potent, reversible, and selective small-molecule inhibitor of factor B, a serine protease that drives the central amplification loop of the AP. Oral administration of the inhibitor prevents KRN-induced arthritis in mice and is effective upon prophylactic and therapeutic dosing in an experimental model of membranous nephropathy in rats. In addition, inhibition of factor B prevents complement activation in sera from C3 glomerulopathy patients and the hemolysis of human PNH erythrocytes. These data demonstrate the potential therapeutic value of using a factor B inhibitor for systemic treatment of complement-mediated diseases and provide a basis for its clinical development.

1 January 2005 in Journal of Molecular Biology
Verified
Journal Article
Closed access
ASAengus Mac Sweeney
Aengus Mac Sweeney
RLRoland Lange
Roland Lange
RFRoberta P.M. Fernandes
Roberta P.M. Fernandes
HSHenk Schulz
Henk Schulz
GDGlenn E. Dale
Glenn E. Dale
COChristian Oefner
Christian Oefner

27 June 2003 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Closed access
PDF file
COChristian Oefner
Christian Oefner
ADAllan D'ARcy
Allan D'ARcy
ASAengus Mac Sweeney
Aengus Mac Sweeney
SPSabine Pierau
Sabine Pierau
RGRana Gardiner
Rana Gardiner
GDGlenn E. Dale
Glenn E. Dale

27 June 2003 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Closed access
PDF file
ADAllan D'Arcy
Allan D'Arcy
ASAengus Mac Sweeney
Aengus Mac Sweeney
AHAlexander Haber
Alexander Haber

24 October 2016 in Nature Chemical Biology
Verified
Journal Article
Closed access
JMJürgen Maibaum
Jürgen Maibaum
SLSha-Mei Liao
Sha-Mei Liao
AVAnna Vulpetti
Anna Vulpetti
NONils Ostermann
Nils Ostermann
SRStefan Randl
Stefan Randl
KAKaren Anderson
Karen Anderson